Structure Therapeutics (GPCR) Tax Provisions (2022 - 2026)
Structure Therapeutics (GPCR) posted quarterly Tax Provisions of $190000.0 for Q1 2026, up 93.88% year-over-year from $98000.0 in Q1 2025, and up 135.71% quarter-over-quarter from -$532000.0 in Q4 2025.
Powered by 
Analysis
Structure Therapeutics (GPCR) Tax Provisions (2022 - 2026) Analysis & Trends
Structure Therapeutics' Tax Provisions history runs 5 years deep, the most recent figure standing at $190000.0 for Q1 2026.
- In Q1 2026, Tax Provisions rose 93.88% year-over-year to $190000.0; the TTM figure through Mar 2026 stood at -$95000.0 (down 123.93% YoY), while the FY2025 annual figure was -$187000.0, down 157.01% from the prior year.
- Tax Provisions for Q1 2026 stood at $190000.0, up from -$532000.0 in the prior quarter.
- The five-year high for Tax Provisions was $405000.0 in Q3 2023, with the low at -$616000.0 in Q4 2023.
- The 5-year median for Tax Provisions is $73000.0 (2022), against an average of $20000.0.
- The sharpest annual moves came in 2023 and 2025: Tax Provisions jumped 454.79% in 2023, then tumbled 445.45% in 2025.
- Structure Therapeutics' Tax Provisions stood at -$120000.0 in 2022, then slumped by 413.33% to -$616000.0 in 2023, then soared by 125.0% to $154000.0 in 2024, then sank by 445.45% to -$532000.0 in 2025, then surged by 135.71% to $190000.0 in 2026.
- Business Quant data shows GPCR's Tax Provisions at $190000.0 in Q1 2026, -$532000.0 in Q4 2025, and $108000.0 in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 292.00 Mn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 230.90 Mn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | -59.00 Mn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 15.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 75.45 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 13.31 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 1.90 Mn |
| 10 | Structure Therapeutics | 10.32 Bn | 10.32 Bn | - | 234,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 234,000.00 |
| Mar 31, 2026 | 190,000.00 |
| Dec 31, 2025 | -29.89 Mn |
| Sep 30, 2025 | 108,000.00 |
| Jun 30, 2025 | 139,000.00 |
| Mar 31, 2025 | 98,000.00 |
| Dec 31, 2024 | -25.84 Mn |
| Sep 30, 2024 | 92,000.00 |
| Jun 30, 2024 | 53,000.00 |
| Mar 31, 2024 | 29,000.00 |
| Dec 31, 2023 | -19.32 Mn |
| Sep 30, 2023 | 405,000.00 |
| Jun 30, 2023 | 118,000.00 |
| Mar 31, 2023 | 25,000.00 |
| Dec 31, 2022 | -120,000.00 |
| Sep 30, 2022 | 73,000.00 |
| Jun 30, 2022 | 64,000.00 |
| Mar 31, 2022 | 60,000.00 |